Tigan suppositories--Ineffective

saluki

Medwatch says the production of Tigan suppositories which
are used for nausea are being discontinued. They have been
found to be innefective.
This does not apply to the oral and injectable forms of this medication.

Here is the alert
--------------------------------------------------------
FDA notified healthcare professionals and consumers that companies must
stop manufacturing and distributing unapproved suppository drug products
containing trimethobenzamide hydrochloride. These products are used to
treat nausea and vomiting in adults and children. The products have
been marketed under various names, including Tigan, Tebamide, T-Gen,
Trimazide, and Trimethobenz. Drugs containing trimethobenzamide in
suppository form lack evidence of effectiveness. This action does not
affect oral capsules and injectable products containing
trimethobenzamide that have been approved by FDA.
FDA urges consumers currently using trimethobenzamide suppositories or
who have questions or concerns to contact their healthcare professional.
Alternative products approved to effectively treat nausea and vomiting
are available in a variety of forms.